Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR model

Background/Aims Studies of human cadaveric pancreas specimens indicate that pancreas inflammation plays an important role in type 1 diabetes pathogenesis. Due to the inaccessibility of pancreas in living patients, imaging technology to visualize pancreas inflammation is much in need. In this study, we investigated the feasibility of utilizing ultrasound imaging to assess pancreas inflammation longitudinally in living rats during the progression leading to type 1 diabetes onset. Methods The virus-inducible BBDR type 1 diabetes rat model was used to systematically investigate pancreas changes that occur prior to and during development of autoimmunity. The nearly 100% diabetes incidence upon virus induction and the highly consistent time course of this rat model make longitudinal imaging examination possible. A combination of histology, immunoblotting, flow cytometry, and ultrasound imaging technology was used to identify stage-specific pancreas changes. Results Our histology data indicated that exocrine pancreas tissue of the diabetes-induced rats underwent dramatic changes, including blood vessel dilation and increased CD8+ cell infiltration, at a very early stage of disease initiation. Ultrasound imaging data revealed significant acute and persistent pancreas inflammation in the diabetes-induced rats. The pancreas micro-vasculature was significantly dilated one day after diabetes induction, and large blood vessel (superior mesenteric artery in this study) dilation and inflammation occurred several days later, but still prior to any observable autoimmune cell infiltration of the pancreatic islets. Conclusions Our data demonstrate that ultrasound imaging technology can detect pancreas inflammation in living rats during the development of type 1 diabetes. Due to ultrasound’s established use as a non-invasive diagnostic tool, it may prove useful in a clinical setting for type 1 diabetes risk prediction prior to autoimmunity and to assess the effectiveness of potential therapeutics.

[1]  J. Nyalwidhe,et al.  Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 Diabetes , 2015, PloS one.

[2]  Ralph Weissleder,et al.  Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients , 2015, Proceedings of the National Academy of Sciences.

[3]  M. V. von Herrath,et al.  Erratum. Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes. Diabetes 2014;63:3880–3890 , 2014, Diabetes.

[4]  M. Atkinson,et al.  New Insight on Human Type 1 Diabetes Biology: nPOD and nPOD-Transplantation , 2014, Current Diabetes Reports.

[5]  Olli Simell,et al.  Innate Immune Activity Is Detected Prior to Seroconversion in Children With HLA-Conferred Type 1 Diabetes Susceptibility , 2014, Diabetes.

[6]  Oliver S. Burren,et al.  A Type I Interferon Transcriptional Signature Precedes Autoimmunity in Children Genetically at Risk for Type 1 Diabetes , 2014, Diabetes.

[7]  Clive Wasserfall,et al.  The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings , 2013, Pediatric diabetes.

[8]  M. Atkinson.  Pancreatic biopsies in type 1 diabetes: revisiting the myth of Pandora’s box , 2014, Diabetologia.

[9]  B. Edwin,et al.  Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study , 2014, Diabetologia.

[10]  D. Harlan,et al.  Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγnull mice treated with alogliptin , 2013, Diabetes, metabolic syndrome and obesity : targets and therapy.

[11]  D. Greiner,et al.  Salicylate Prevents Virus-Induced Type 1 Diabetes in the BBDR Rat , 2013, PloS one.

[12]  F. Urano,et al.  Pathological endoplasmic reticulum stress mediated by the IRE1 pathway contributes to pre-insulitic beta cell apoptosis in a virus-induced rat model of type 1 diabetes , 2013, Diabetologia.

[13]  B. Croker,et al.  Increased Complement Activation in Human Type 1 Diabetes Pancreata , 2013, Diabetes Care.

[14]  Qibin Zhang,et al.  Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes , 2013, The Journal of experimental medicine.

[15]  M. Atkinson,et al.  Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes. , 2012, JAMA.

[16]  M. Atkinson,et al.  Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes , 2012, Diabetes/metabolism research and reviews.

[17]  M. Wilkins,et al.  Children With Islet Autoimmunity and Enterovirus Infection Demonstrate a Distinct Cytokine Profile , 2012, Diabetes.

[18]  M. Atkinson,et al.  Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients , 2012, The Journal of experimental medicine.

[19]  Chaoxing Yang,et al.  The BB rat as a model of human type 1 diabetes. , 2012, Methods in molecular biology.

[20]  D. Zipris.  Innate immunity in type 1 diabetes , 2011, Diabetes/metabolism research and reviews.

[21]  J. Leszyk,et al.  Haptoglobin as an early serum biomarker of virus-induced autoimmune type 1 diabetes in biobreeding diabetes resistant and LEW1.WR1 rats , 2010, Experimental biology and medicine.

[22]  R. Planas,et al.  Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery. , 2010, Immunology letters.

[23]  Martin Vingron,et al.  A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk , 2010, Nature.

[24]  Jeffrey A. Bluestone,et al.  Genetics, pathogenesis and clinical interventions in type 1 diabetes , 2010, Nature.

[25]  D. Zipris.  Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanisms. , 2009, Clinical immunology.

[26]  D. Greiner,et al.  Failure of alpha-galactosylceramide to prevent diabetes in virus-inducible models of type 1 diabetes in the rat. , 2009, In vivo.

[27]  M. Rewers,et al.  IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. , 2008, Human molecular genetics.

[28]  M. Hessner,et al.  Identification of a Molecular Signature in Human Type 1 Diabetes Mellitus Using Serum and Functional Genomics1 , 2008, The Journal of Immunology.

[29]  M. Rewers,et al.  IFIH 1 polymorphisms are significantly associated with type 1 diabetes and IFIH 1 gene expression in peripheral blood mononuclear cells , 2008 .

[30]  U. Boggi,et al.  Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients , 2007, Proceedings of the National Academy of Sciences.

[31]  D. Clayton,et al.  A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region , 2006, Nature Genetics.

[32]  S. Virtanen,et al.  Environmental triggers and determinants of type 1 diabetes. , 2005, Diabetes.

[33]  R. Weissleder,et al.  Imaging inflammation of the pancreatic islets in type 1 diabetes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Wen,et al.  The Effect of Innate Immunity on Autoimmune Diabetes and the Expression of Toll-Like Receptors on Pancreatic Islets1 , 2004, The Journal of Immunology.

[35]  D. Greiner,et al.  Rat models of type 1 diabetes: genetics, environment, and autoimmunity. , 2004, ILAR journal.

[36]  J. Hillebrands,et al.  Infections That Induce Autoimmune Diabetes in BBDR Rats Modulate CD4+CD25+ T Cell Populations12 , 2003, Journal of Immunology.

[37]  M. Atkinson,et al.  Type 1 diabetes: new perspectives on disease pathogenesis and treatment , 2001, The Lancet.

[38]  D. Lombardo,et al.  Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. , 1999, Diabetes.

[39]  D. Greiner,et al.  Autoimmune Destruction of Islets Transplanted Into RT6-Depleted Diabetes-Resistant BB/Wor Rats , 1990, Diabetes.